Financial insights of GMED

MyFinsight

For the quarter ending 2025-09-30, GMED made $769,048K in revenue. $119,654K in net income. Net profit margin of 15.56%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Net sales	769,048	745,342	598,121	625,705
Cost of sales (exclusive of amortization of intangibles)	252,533	248,765	195,397	270,515
Research and development	38,067	39,954	33,062	35,380
Selling, general and administrative	313,597	303,622	242,799	240,738
Litigation settlement, expense	-	-	-	-676
Amortization of intangibles	29,843	30,189	28,802	30,076
Acquisition-related costs	-2,713	33,156	1,057	-3,617
Restructuring costs	358	13,547	-	5,191
Operating income/(loss)	137,363	76,109	97,004	48,098
Interest income/(expense), net	1,455	693	1,681	-775
Foreign currency transactional gain/(loss)	-161	38	4,270	10,279
Bargain purchase gain	3,800	110,561	-	-
Other income/(expense)	1,537	772	713	-570
Total other income/(expense), net	6,631	112,064	6,664	8,934
Income/(loss) before income taxes	143,994	188,173	103,668	57,032
Income tax provision/(benefit)	25,028	-14,673	28,206	5,196
Net income/(loss)	118,966	202,846	75,462	51,836
Unrealized gain/(loss) on marketable securities	30	2	315	912
Foreign currency translation gain/(loss)	658	12,404	4,379	3,976
Total other comprehensive income/(loss), net of tax	688	12,406	4,694	4,888
Comprehensive income/(loss)	119,654	215,252	80,156	56,724

Earnings per share, basic	0.88	1.5	0.55	0.38
Earnings per share, diluted	0.88	1.49	0.54	0.38
Weighted average number of shares outstanding, basic	134,502,000	135,205,000	136,757,000	135,615,000
Weighted average number of shares outstanding, diluted	135,394,000	136,499,000	139,774,000	138,062,000